Revolution Medicines Income from Continuous Operations 2018-2024 | RVMD
Revolution Medicines income from continuous operations for the twelve months ending September 30, 2024 was $-0.567B, a 71.14% increase year-over-year.
- Revolution Medicines annual income from continuous operations for 2023 was $-0.436B, a 75.46% increase from 2022.
- Revolution Medicines annual income from continuous operations for 2022 was $-0.249B, a 32.93% increase from 2021.
- Revolution Medicines annual income from continuous operations for 2021 was $-0.187B, a 72.98% increase from 2020.